<DOC>
	<DOCNO>NCT00260039</DOCNO>
	<brief_summary>This dose-ranging study evaluate investigational vaccine follow objective : ( 1 ) To demonstrate vaccine well-tolerated woman ( 2 ) To evaluate immune response woman 16 23 year age enrollment .</brief_summary>
	<brief_title>Broad Spectrum HPV Vaccine Dose Ranging Study ( V502-001 )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Lifetime history 04 sexual partner History abnormal PAP test abnormal cervical biopsy result ; history external genital/vaginal wart ; history positive HPV test</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>